Medicine and Dentistry
Activated Charcoal
32%
Acute Leukemia
32%
Acute Promyelocytic Leukemia
16%
Antithrombotic
24%
Assay
39%
Betrixaban
32%
Biological Marker
32%
Blood Clotting
8%
Blood Clotting Factor 10a Inhibitor
6%
Bone Regeneration
32%
Carcinogenesis
8%
Cell Adhesion Molecule
16%
Cells
48%
Coagulation
16%
Complication
12%
Disseminated Intravascular Coagulation
40%
Endothelial Cell
16%
Erythrocyte
16%
Erythrocyte Concentrate
32%
Flow Cytometry
5%
Hematologic Malignancy
7%
Hemisphere
9%
Hemostat
35%
Heparin
8%
Hydroxylapatite
13%
Inpatient
36%
Leukemia Cell
8%
Malignant Neoplasm
32%
Membrane Microparticle
64%
Membrane Protein
8%
Microparticle
32%
Partial Thromboplastin Time
6%
Patient
48%
Phospholipid
26%
Platelet-Rich Fibrin
32%
Procoagulant
100%
Programmed Cell Death
8%
Protein C
8%
Proteoglycan
8%
Target Cell
8%
Therapeutic Procedure
15%
Thrombin
27%
Thrombocyte Adhesion
8%
Thromboplastin
61%
Thrombosis
40%
Tissue Factor Pathway Inhibitor
8%
Vascular Bundle
8%
Vascular Endothelium
32%
Venous Thromboembolism
22%
Viper Venom
6%
Nursing and Health Professions
Adverse Event
5%
Biocompatibility
5%
Collagen
5%
Device Material
36%
Granuloma
10%
Hydroxyapatite
13%
Incision
5%
Microsurgery
32%
Middle Ear Surgery
5%
Operating Room
5%
Parameters
5%
Patient
32%
Platelet-Rich Fibrin
64%
Processing
5%
Time
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Leukemia
32%
Betrixaban
32%
Blood Clotting Factor 10a Inhibitor
7%
Daboia russellii
5%
Disseminated Intravascular Clotting
32%
Ethanolamine
5%
Glutaraldehyde
5%
Prothrombin
7%
Thromboplastin
7%
Tissue Factor Pathway Inhibitor
32%
Viper Venom
7%
